Skip to content
Search
Register / Sign in
MSCI China
|
MSCI China Small-Cap
|
Hang Seng Index
|
Hang Seng China Enterprise
Categories
IPO
Ecommerce
Finance
Social Media/Entertainment
Consumer
Education
Healthcare/biotech
New Energy
AI/Infrastructure/Resources
Property
China ESG Focus
Fast News
Expert Corner
Audio/Video
IPO
About
Who We Are
Our Writers
Partner with us
Contact Us
Join us
Eng
简中
繁中
Menu
Categories
IPO
Ecommerce
Finance
Social Media/Entertainment
Consumer
Education
Healthcare/biotech
New Energy
AI/Infrastructure/Resources
Property
China ESG Focus
Fast News
Expert Corner
Audio/Video
IPO
About
Who We Are
Our Writers
Partner with us
Contact Us
Join us
Stories About 7630.HK
Precision-drug maker Impact Therapeutics ignites IPO frenzy
2026-05-14
Recent Articles
June 9, 2026
BRIEF: Chairman Tang Ning boosts indirect stake in Yiren Digital
YRD.US
June 9, 2026
BRIEF: Senasic launches $125 million Hong Kong IPO
6675.HK
June 9, 2026
Anker swims beyond its signature chargers with ‘shallow sea’ approach
300866.SHE
June 9, 2026
BRIEF: Majority shareholder boosts stake in China Hongqiao
1378.HK
June 9, 2026
Starved for better profits, Fubei chases IPO to fill its funding bowl
June 8, 2026
BRIEF: Unisound unveils new ‘agent-driven large model’
9678.HK
June 8, 2026
BRIEF: Shimai Pharma gets CSRC nod for Hong Kong IPO
RELATED ARTICLES
No related posts.
Discover hidden China stock gems in our weekly newsletter
Email Address *
Newsletter Type
English Version
Chinese Version
Sign-up
Follow us
Facebook
Twitter
Linkedin
Weixin
Weibo
Youtube
Subscribe to Our Free eNewsletter
Subscribe
Check out our content with some of our syndication partners
